Equity
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Incyte Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively increased by 1.0% to $200K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.6%, from $193K to $200K. Over 5 years (FY 2020 to FY 2025), Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively shows relatively stable performance with a -2.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2014
Last reportedQ1 2026Apr 28, 2026
Metric ID:
equity_common_stock_valueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $220K | $221K | $221K | $221K | $222K | $222K | $223K | $223K | $223K | $224K | $224K | $224K | $191K | $192K | $193K | $193K | $194K | $196K | $198K | $200K |
| QoQ Change | — | +0.5% | +0.0% | +0.0% | +0.5% | +0.0% | +0.5% | +0.0% | +0.0% | +0.4% | +0.0% | +0.0% | -14.7% | +0.5% | +0.5% | +0.0% | +0.5% | +1.0% | +1.0% | +1.0% |
| YoY Change | — | — | — | — | +0.9% | +0.5% | +0.9% | +0.9% | +0.5% | +0.9% | +0.4% | +0.4% | -14.3% | -14.3% | -13.8% | -13.8% | +1.6% | +2.1% | +2.6% | +3.6% |
Range$191K – $224K
CAGR-2.0%
Avg YoY Growth-2.6%
Median YoY Growth+0.7%
Current Streak7 quarters growth
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively at Other Companies
Frequently Asked Questions
- What is Incyte's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
- Incyte (INCY) reported common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively of $200K in Q1 2026.
- How has Incyte's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively changed year-over-year?
- Incyte's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively increased by 3.6% year-over-year, from $193K to $200K.
- What is the long-term trend for Incyte's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
- Over 5 years (2020 to 2025), Incyte's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively has grown at a -2.0% compound annual growth rate (CAGR), from $219K to $198K.